Pfizer, BioNTech to limit delays of vaccine shipments to one week

0:00
play article
Subscribers can listen to this article
A member of a German Red Cross mobile vaccination team prepares the Pfizer-BioNTech Covid-19 vaccine for employees and inhabitants of a retirement nursery in Dillenburg, Germany. Picture: Kai Pfaffenbach/Reuters
A member of a German Red Cross mobile vaccination team prepares the Pfizer-BioNTech Covid-19 vaccine for employees and inhabitants of a retirement nursery in Dillenburg, Germany. Picture: Kai Pfaffenbach/Reuters

Pfizer and BioNTech said Saturday they will limit the delays of their vaccine deliveries to just one week, after fears in Europe that shipments of the jabs could be slowed for up to a month.

The US drugmaker and its German partner "have developed a plan that will allow the scale-up of manufacturing capacities in Europe and deliver significantly more doses in the second quarter," they said in a joint statement.

"As a result, our facility in Puurs, Belgium will experience a temporary reduction in the number of doses delivered in the upcoming week."

Pfizer and BioNTech pledged that deliveries would be back to the original schedule to the European Union from the week of 25 January, with increased delivery from the week of 15 February.

"To accomplish this, certain modifications of production processes are required now."

Pfizer had said Friday it would delay shipments of the jabs over the next three to four weeks due to works at its key plant in Belgium.

It said the modifications at the Puurs factory were necessary in order to ramp up its production capacity from mid-February.

In hard-hit Europe, the statement raised concerns that the delays could further slow a vaccine rollout that has already faced heavy criticism.

Six EU health ministers signed a letter to the European Commission on Friday to express "severe concern" over the delivery delays.

The Pfizer-BioNTech vaccine, which was developed at record-breaking speed, became the first to be approved for general use by a Western country on 2 December when Britain gave it the go-ahead.


Did you know you can comment on this article? Subscribe to News24 and add your voice to the conversation.
We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
Would you choose to continue working from home after the coronavirus lockdown if given the option?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, it's much better for me
40% - 7991 votes
No ways! I can't wait to get back to the office
12% - 2329 votes
A mixture of both would suit me best
48% - 9700 votes
Vote
USD/ZAR
14.33
(+0.8)
GBP/ZAR
19.81
(+1.5)
EUR/ZAR
17.17
(+1.3)
AUD/ZAR
11.08
(+0.9)
JPY/ZAR
0.13
(+1.1)
Gold
1,778.50
(+0.9)
Silver
26.04
(+0.7)
Platinum
1,204.25
(+0.6)
Brent Crude
66.94
(+0.5)
Palladium
2,766.81
(+0.8)
All Share
68,699
(+1.3)
Top 40
62,898
(+1.3)
Financial 15
12,446
(+0.8)
Industrial 25
89,364
(+0.8)
Resource 10
70,350
(+2.2)
All JSE data delayed by at least 15 minutes Iress logo